Gopinath Upamaka
Cardiovascular Disease · Toledo, OHNPI 1750385670
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $7,518 of the $9,360 with a category attached, or 80.3%. 12 manufacturers reported payments, led by Sanofi-aventis U.S. LLC at 51.6% of the total. Reporting peaked in 2019 at $8,957 and has fallen 97.7% since, to $204 in 2022.
Across 69 payments — averaging $135.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi-aventis U.S. LLC$5K
- Regeneron Healthcare Solutions, Inc.$4K
- Johnson & Johnson$280
- Abbott$229
- AstraZeneca$42
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$41
- plus $124 from 6 others
Across 43 payments — averaging $2992.41 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Livanova USA, Inc.$108K
- Merck$21K
What the payments were for
- Speaking & faculty fees$7,51880%
- Travel & lodging$7528%
- Food & beverage$1,08412%
- Education$50%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi-aventis U.S. LLC | 13 | $4,831 |
| Regeneron Healthcare Solutions, Inc. | 10 | $3,812 |
| Johnson & Johnson | 19 | $280 |
| Abbott | 15 | $229 |
| AstraZeneca | 3 | $42 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $41 |
| Novartis | 2 | $34 |
| Boehringer Ingelheim | 1 | $27 |
| Lundbeck LLC | 1 | $18 |
| Pfizer | 1 | $15 |
| Esperion Therapeutics, Inc. | 1 | $15 |
| E.r. Squibb & Sons, L.L.C. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PRALUENT$8,068
How this compares
$9,360 in reported general payments places this provider in the 80th percentile of 827 cardiovascular disease providers in Ohio.
Other cardiovascular disease in Toledo
- Rajendra KattarToledo$37K
- Guilherme AttizzaniCleveland$1.3M
- Gregory LamCircleville$428K
- Emil HayekHudson$379K
- Abraham LincoffCleveland$369K
- Oussama WazniCleveland$367K
- Ian NeelandCleveland$329K
- Kamal ShemisaCincinnati$314K
- Mehdi ShishehborElyria$237K
- Abdu HawwaGarfield Hts$234K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.